Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 19Head and Neck Neoplasms 13Nasopharyngeal Carcinoma 12Oropharyngeal Neoplasms 8Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Laryngeal Neoplasms 3Nasopharyngeal Neoplasms 2Carcinoma, Squamous Cell 2Tonsillar Neoplasms 1Tobacco Use Disorder 1Smoking Cessation 1Smoking 1Pharyngeal Neoplasms 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Hypopharyngeal Carcinoma 1Laryngeal Diseases 1Carcinoma 1

Interventions

Cisplatin 2motexafin gadolinium 1Standard of Care 1Radiation 1Practice Guidelines as Topic 1Erlotinib Hydrochloride 1Docetaxel 1Chemoradiotherapy 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tonsillar Neoplasms × Chemoradiotherapy × Head & Neck × Clear all
NCT00140556 2013-01-18

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Duke University

Phase EARLY_PHASE1 Completed
28 enrolled 8 charts
Head & Neck

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡